Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Survodutide, a dual glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist, has demonstrated significant weight reduction in adults with obesity in recent Phase 2 clinical trials. Published in the New England ... Read More
Continuous Coverage
When former New York City deputy mayor and Giuliani ally Michael Mastro reemerged in 2026 as a vocal…
Kraken Robotics, a stealthy defense-tech upstart, just dropped its Q2 earnings whisper: a 34% revenue jump to $187M,…
Recent clinical data indicates that elevated maternal eosinophil counts—a type of white blood cell involved in allergic responses—are…
The release of The Legend of Zelda: Ocarina of Time manga Chapter 2, Link Sets Off, on Instagram…
Denny Hamlin reached a career milestone at Michigan International Speedway by securing his 63rd NASCAR Cup Series win,…
SpaceX, Rocket Lab, and China’s private launch sector are accelerating atmospheric damage by injecting 360 metric tons of…
Global Affairs
When a French woman vaped on a flight and was banned from flying for life, the incident sparked…
Markets And Money
PLN (IDX: PLNJ) leadership shakeup rumors dismissed by CEO Danantara—here’s why the market should ignore the noise and…
Digital Culture
vivo’s X Fold6, running OriginOS 6 Fold, has been spotted at the French Open with a Snapdragon 8…
Science And Wellbeing
Recent longitudinal research indicates that increased time spent in outdoor play during the preschool years is significantly associated…
Screen And Sound
Idris Elba’s 2026 remarks on James Bond’s racial casting limits spark debate over Hollywood’s diversity progress, with industry…
Fixtures And Form
The Architectural Shift: Why Tony Brown’s Return Reshapes the All Blacks’ Tactical Identity New Zealand Rugby has secured…
